| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |